ReviewCurrent hypertension reports2002
Angiotensin II-mediated signal transduction pathways.
Review in Current hypertension reports, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 67 citations in OpenAlex.
- SNRK facilitates cardiac repair associated with nonischemic fibrosis: regulating transforming growth factor-beta1 levels in atrial cardiomyocytes.Regenerative medicine reports · 2025Article
- Inhibiting AGTR1 reduces AML burden and protects the heart from cardiotoxicity in mouse models.Science translational medicine · 2024Article
- Integrative analysis of Iso-Seq and RNA-seq reveals dynamic changes of alternative promoter, alternative splicing and alternative polyadenylation during Angiotensin II-induced senescence in rat primary aortic endothelial cells.Frontiers in genetics · 2023Article
- Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease.Clinical science (London, England : 1979) · 2020Review
- Candesartan ameliorates vascular smooth muscle cell proliferation via regulating miR-301b/STAT3 axis.Human cell · 2020Article
- Cardiomyocyte-SpecificJournal of the American Heart Association · 2019Article
- Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.Journal of molecular and cellular cardiology · 2014Article
- Angiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failure.Journal of cardiac failure · 2012Article
- Oxidative stress-mediated effects of angiotensin II in the cardiovascular system.World journal of hypertension · 2012Article
- Angiotensin II induces afterdepolarizations via reactive oxygen species and calmodulin kinase II signaling.Journal of molecular and cellular cardiology · 2011Article
- Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB.Journal of inflammation (London, England) · 2010Article
- Experimental validation of miRNA targets.Methods (San Diego, Calif.) · 2008Review
- TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways.American journal of physiology. Lung cellular and molecular physiology · 2007Article
- The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding.The Journal of biological chemistry · 2007Article
- The renin-angiotensin system and atherosclerosis.Current hypertension reports · 2006Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
The renin-angiotensin system is one of the major cardiovascular systems that controls blood volume, peripheral vascular tone, and blood pressure. Recent studies indicate important roles for angiotensin II in inflammation, atherosclerosis, and congestive heart failure as well. It is gradually becoming clear that angiotensin II exerts effects on the cardiovascular system through several unique mechanisms, including the availability of two different angiotensin II receptors, recruitment of protein tyrosine kinase activity, and receptor tyrosine kinase transactivation. This review discusses the diverse mechanisms of angiotensin II-mediated signal transduction pathways and the various effects of angiotensin II on the cardiovascular system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.